MENU
CORT
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Corcept Therapeutics (CORT) Ownership - Who owns Corcept Therapeutics?
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol... Show more
Industry: #Pharmaceuticals Other
Profile
Industry
Pharmaceuticals Other
Address
149 Commonwealth Drive
Phone
+1 650 327-3270
Employees
352
Web
https://www.corcept.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
8.84B
P/E Ratio
68.14
Total Cash
383.33M
Projected Growth
N/A
Total Debt
6.94M
Revenue
675.04M
Risk (Beta)
1.07
Dividend Yield
N/A
Total Cash/Share
3.63
Total Debt/Equity
374.71
Revenue/Share
5.95 USD as % of share price
Fundamentals
CORT
Capitalization
8.84B
P/E Ratio
68.14
Risk (Beta)
1.07
Dividend Yield
N/A
Total Cash
383M
Total Cash/Share
3.63
Total Debt
6.94M
Total Debt/Equity
374.71
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
5.95%
Revenue
675M
ROE
N/A
Book Value
680M
P/B Ratio
13.00
Cash Flow
N/A
Earnings
1.35
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
136K
Current Ratio
3.35
Current Revenue Per Employee
363780.00
Dividends Per Share - Security
N/A
EBITDA
138M
Float
N/A
Float - Current
N/A
Gross Income Margin
98.37
Revenue To Assets
19.11
Shares Held By Institutions
6.39B
Shares Outstanding - Current
106M
Total Liabilities
161M
Total Volume MTD
N/A
Value
-1
Gain YTD
66.323
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a maker of drugs for the treatment of severe psychiatric and neurological diseases
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
149 Commonwealth Drive
Phone
+1 650 327-3270
Employees
352
Web
https://www.corcept.com